In the view of the analysts at Goldman Sachs, USD/JPY is likely to drop amid a rebound expected in the yen and Fed rate hike bets pushed back.
“In the medium-term USD/JPY may rise, due to boosts from the vaccine surge in growth and inflation.”
“But then heads lower as aggressive Fed hike bets are cut back ...”
"We expect no hikes until 2024, whereas markets price about three hikes before then.0"
"In the second half of 2021, when we will be on the other side of the vaccine-led surge in US activity, and when Japan's own vaccination campaign should be catching up, we expect USD/JPY to turn lower again."
“Speculative yen shorts have accumulated despite the lack of evidence of Japanese foreign bond purchases accelerating.”
“A swing from longs to shorts in Q1 likely helped yen depreciation and this pressure on the currency is likely gone.”
“The yen is cheap relative to longer-term valuation.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.